PMCB
PharmaCyte Biotech Inc
Price:  
1.11 
USD
Volume:  
4,487.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PMCB Relative Valuation

-45.9%
Upside

As of 2025-07-07, the Relative Valuation of PharmaCyte Biotech Inc (PMCB) is 0.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.11 USD, the upside of PharmaCyte Biotech Inc based on Relative Valuation is -45.9%.

The range of the Relative Valuation is 0.02 - 1.18 USD.

Range Selected
Trailing P/E multiples 0.4x - 0.4x 0.4x
Forward P/E multiples 0.4x - 0.4x 0.4x
Fair Price 0.02 - 1.18 0.60
Upside -98.2% - 6.4% -45.9%
1.11 USD
Stock Price
0.60 USD
Fair Price

PMCB Relative Valuation - Historical P/E Data

Date P/E
2025-05-07 0.37
2025-05-06 0.38
2025-05-05 0.41
2025-05-02 0.41
2025-05-01 0.40
2025-04-30 0.42
2025-04-29 0.42
2025-04-28 0.41
2025-04-25 0.41
2025-04-24 0.41
2025-04-23 0.40
2025-04-22 0.39
2025-04-21 0.38
2025-04-17 0.40
2025-04-16 0.39
2025-04-15 0.43
2025-04-14 0.41
2025-04-11 0.42
2025-04-10 0.39
2025-04-09 0.41
2025-04-08 0.41
2025-04-07 0.39
2025-04-04 0.42
2025-04-03 0.42
2025-04-02 0.44
2025-04-01 0.44
2025-03-31 0.42
2025-03-28 0.45
2025-03-27 0.47
2025-03-26 0.50
2025-03-25 0.53
2025-03-24 0.53
2025-03-21 0.54
2025-03-20 0.57
2025-03-19 0.57
2025-03-18 0.51
2025-03-17 0.54
2025-03-14 0.54
2025-03-13 0.57
2025-03-12 0.56
2025-03-11 0.60
2025-03-10 0.60
2025-03-07 0.60
2025-03-06 0.60
2025-03-05 0.61
2025-03-04 0.58
2025-03-03 0.58
2025-02-28 0.60
2025-02-27 0.59
2025-02-26 0.58